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There is a high degree of concern regarding the secure use of plant
extracts and, for this very reason, preclinical and clinic
toxicological evaluation of these extracts are needed. With the aim
to assure the quality and the safety of the extract and due to the
scarcity of literature information about Pariparoba extract toxicity,
our purpose was to investigate the acute and subchronic toxicity
of the standardized ethanolic dried root extract of Pothomorphe
umbellata L. Miq. This extract was administered orally to adult
swiss mice and wistar rats and the mutagenic potencial of the extract
was also evaluated. The extract showed to be non toxic.
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INTRODUCTION
Pothomorphe umbellata L. Miq. (Piperaceae),
known in Brazil as Pariparoba or Capeba, grows in the
states of São Paulo, Minas Gerais, Espírito Santo and Bahia
(Kijjoa et al., 1980; Van den Berg, 1993; Panizza, 1997).
Roots and leaves are widely used for the treatment of liver
diseases and inflammatory disorders in tropical South
America (Kijjoa et al., 1980; Barros et al, 1996). For this
reason the roots of Pothomorphe umbellata L. Miq.
were included in the first edition of the Brazilian
Pharmacopoeia (Silva, 1929). The members of the
Piperaceae family are rich in substances such as phenols,
phenolic esters, terpenoids and ethers (Gibbs, 1974; Calle,
1983). Kijjoa et al., (1980), isolated from Pothomorphe
umbellata L. Miq. a phenolic compound, 4-
nerolidylcatechol, with high antioxidant activity in vitro
(Barros et al., 1996). There is a high degree of concern
regarding the safety use of plant extracts. With the aim to
ensure the quality and safety of phytomedicines, the
National Agency of Sanitary Surveillance of Brasil
(ANVISA) published on February 24, 2000, the Resolution
n°17 (Brazil, 2000) establishing that phytomedicines should
be submitted to pre-clinical and clinical toxicological and
pharmacological assays. As no information exists in the
scientific literature about pariparoba extract toxicity, our
purpose was to investigate the oral acute and subchronic
toxicity of the standardized ethanolic dried root extract of
Pothomorphe umbellata L. Miq. to laboratory animals.
MATERIAL AND METHODS
Plant material and extract preparation
The roots of Pothomorphe umbellata L. Miq. were
collected in the “Armando de Salles Oliveira” campus of
the University of São Paulo, at São Paulo city (South-east
of Brazil). An herbarium specimen is deposited in the De-
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partamento de Botânica, Instituto de Biociências, Univer-
sidade de São Paulo (Sonia and Cris n°01). Ethanol:water
(1:1) extract was prepared from dried powdered roots.
Plant material was percolated with ethanol:water 1:1
according to the Brazilian Pharmacopoeia (Silva, 1929),
and then dried by lyophilization. This extract was referred
as crude extract and employed for the toxicological assays.
Standardization of the extract
4-nerolidylcatechol (4-NC) was employed as a
marker for the extract standardization. The concentration
of 4-NC was determined in the crude extract of
Pothomorphe umbellata L. Miq. by high performance
liquid chromatography. The chromatographic system
consisted of a Consta Metric 3200 bomb, coupled with a
UV spectrophotometer detector (Waters model 481),
settled at wavelength of 282 nm. A Phenomenex PP18
5 µ (4.6x250 mm) column was used with a mobile phase of
methanol:water 9:1 with a flux of 0,8 mL/min. Pure 4-NC,
kindly provided by Professor Massuo Jorge Kato, Institu-
to de Química, Universidade de São Paulo, was used as
standard. The dried crude extract employed in this study
contained 6,5% of 4-nerolidylcatechol.
Animals
Adult Swiss mice (32 ± 7,5 g body weight) and
Wistar rats (200 ± 30 g body weight) were used for the
assessment of the acute toxicity. Animals of both sexes
(females nulliparous and no pregnant) were randomly
assigned to control and treated groups (5 animals per group/
cage). For the subchronic study male and female
(nulliparous and no pregnant) adult Wistar rats were
employed. Animals were randomly assigned to control and
treated groups (10 males and 10 females per group).
Animals received food (Labina®-Purina) and water ad
libitum (Brito, 1994).
Acute toxicity evaluation
Mice and rats received by gavage 1, 2 or 5g/k of
body weight (Limit test) of an aqueous suspension of dried
root ethanolic extract of Pothomorphe umbellata L. Miq
(United States, 1992; Brito, 1994; Brasil, 1996). Control
group received isovolumetric amounts of water. Mice and
rats were observed thoroughly during the first 24 hours for
the onset of any immediate toxic signs and daily during the
13 days observation period to record any delayed acute
effects. All animals were killed after 14 days according to
the Ethical Principles of Animal Experimentation proposed
by the COBEA (Colégio Brasileiro de Experimentação
Animal, 2003).
Subchronic toxicity evaluation
Rats were dosed by gavage (500mg/kg body weight)
for a period of 40 days (5 days per week) with an aqueous
suspensions of the ethanolic crude extract of Pothomorphe
umbellata L. Miq (United States, 1992; Vaittinen et al.,
1995; Krysiak et al., 1996). Food and water consumption and
body weight were measured three days per week. During
the experimental period all animals were observed
thoroughly for the onset of any signs of toxicity. At the end
of the experiment, the animals were killed under light ether
anesthesia according to the Ethical Principles of Animal
Experimentation proposed by the COBEA (Colégio Brasi-
leiro de Experimentação Animal , 2003) and selected organs
(liver, kidney, spleen and heart), after macroscopic
observation, were excised and processed for routine
microscopic examination. Blood samples were collected for
hematological and biochemical analysis.
Histopathological studies
Slices of liver, kidney, spleen and heart were fixed in
formaldehyde 5%, embedded in paraffin wax, sectioned at
5µ and stained with haematoxylin and eosin (Pearse,
1968). Detailed microscopic examination was carried out
in those organs of both control and treatment groups of both
sexes.
Hematological analysis
Blood samples were collected under 10% EDTA/
saline pH 7.2 and examined for hemoglobin concentration,
packed cell volume, total erythrocyte count, and total and
differential leukocytes counts (Kjeldsberg, 1998; Moura,
1982; Smith, 1995).
Biochemical analysis of serum
Whole blood samples were collected and allowed to
clot. After centrifugation the serum was analyzed for
cholesterol, triglycerides, glucose, alanine
aminotransferase (ALT) and aspartate aminotransferase
(AST) employing standard kits (SERA-PAK®Cholesterol
Fast Color - Bayer, SERA-PAK®Triglycerides Fast Color
- Bayer, SERA-PAK®Glucose Fast Color – Bayer, IFCC
– Roche and IFCC – Roche, respectively). Serum samples
were also analyzed for creatinine (Larsen, 1972), total
protein (Gornall et al., 1949) and urea (Henry, 1991).
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In vivo mutagenic potential
Considering that root extracts of Pothomorphe
umbellata L. Miq are rich in 4-nerolydilcatechol, a
phenolic derivative, and due to the potential mutagenic
properties of this class of compounds, the mutagenic
assessment of the extract was evaluated (Madrigal-
Bujaidar et al., 1998; Wong & McLean, 1999).
The in vivo bone marrow micronucleus test was the
assay of choice. It is a mammalian in vivo test, which
detects damage to the chromosomes or to the mitotic
apparatus by chemicals (United States, 1992). The
micronucleus test is used to identify mutagenic
compounds, that is, those that are capable of inducing
structural changes in chromosomes (WHO, 1985)
The test is based on the increase in the frequency of
micronucleated polychromatic erythrocytes in bone
marrow of treated animals (United States, 1992). In the
micronucleus test, mutagenic effects can be measured
indirectly by counting small nuclei (one or several for cell)
in interphase cells. These nuclei are formed from acentric
chromosome fragments or whole chromosomes, which lag
behind anaphase of cell division (WHO, 1985; United
States, 1992; Rabello-Gay, 1991). Micronucleus test is,
usually, carried out in mice. Animals are treated and
polychromatic erythrocytes of bone marrow are stained
and examined (Hodgson, 1997).
Adult male Swiss mice (35 g mean body weight)
were acclimatized during three days before the start of the
study receiving food (Labina®-Purina) and water ad
libitum (Walker, 1984). The animals were randomly
distributed in 5 groups (5 animals each). The first group,
negative control, received isovolumetric amounts of
distillated water. The second group, positive control,
received 50 mg/Kg of the cyclophosphamide (Ribeiro et
al., 1993). Treated groups received 1, 2 or 5g/Kg (Limit
test) of an aqueous suspension of dried root ethanolic
extract of Pothomorphe umbellata L. Each animal was
dosed twice in and interval of 24 hours.
The animals were killed by cervical dislocation 24 h
after the last treatment. Both femurs were removed,
washed, and the epiphyses were cut to expose the
medullary channel. Bone marrow was aspirated and
suspended several times until its spread through serum as
a fine suspension. The material was centrifuged at 2,000
rpm for 5 minutes. The supernatant was removed, the
sediment carefully aspirated with pipette, and one drop
placed on a clean slide. A fine smear was obtained with the
aid of a coverslip. The slides were stained with Wright and
Giemsa (Rabello-Gay, 1991) and analyzed under light
microscopy with a 100x immersion objective. The number
of micronucleated cells was counted in 1,000 per animal
(Rabello-Gay, 1991). The rate of monochromatic
erythrocytes to polychromatic erythrocytes was
determinate in the same sample to describe the cytotoxic
effect (Mengs et al., 1997).
Statistical analysis
Body weight, water and food intake, biochemical
and hematological determinations were analyzed by the
Student “t” and Mann-Whitney tests. For the micronucleus
analysis the Fisher test was employed to detect statistical
differences between control and treated groups (Pereira,
1991). All comparison tests were two-tailed, and a
probability level of Pd”0.05 was considered significant.
RESULTS
Acute toxicity evaluation
Mice and rats administered Pothomorphe
umbellata L. Miq. root extract did not develop any clinical
signs of toxicity either immediately or during the post-
treatment period with 1, 2 and 5 g/kg. No mortality
occurred in both species either immediately or during the
14-day observation period. 5 g/kg body weight dose was
considered as the “Limit test” as recommend by the acute
toxicity testing procedures. Administration of further higher
doses was considered physiologically unsound and, is not
generally recommended.
Oral administered Pothomorphe umbellata L. Miq.
root extract did not cause any appreciable alterations in
water and food intake (data not shown) during 2 weeks in
both species. Further, body weight gain during the
observation period among the treated animals was
comparable to their respective controls. No sex-related
differences were evident in either species.
Subchronic toxicity in rats
Administration of Pothomorphe umbellata L. Miq.
root extract for 40 days produced no signs of toxicity or
mortality during the experimental period, in both sexes. The
treated animals did not show any significant alteration in
water or food consumption, nor in body weight during the
experimental period. Furthermore, the animals showed no
symptoms of diarrhea, piloerection, convulsion, and
sleepiness.
Hematological parameters in the Pothomorphe
umbellata L. Miq. root extract-treated rats were not
markedly changed (Table I).
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Serum clinical chemistry showed only a few
consistent changes. Among the serum biochemical
parameters tryglycerides were increased by 39% in
treated male rats and AST activity was 24% decreased in
females. Serum protein content decreased in both sexes
(Table II).
Macro and microscopic observations indicated no
alteration in liver, spleen, kidneys and heart of the treated
animals with 500 mg/kg of Pothomorphe umbellata L.
Miq. root extract.
In the mutagenic assessment of Pothomorphe
umbellata L. Miq. root extract, treated animals showed a
statistically low frequency of micronuclei in relation to the
positive group (Table III) .
This frequency was very near of the spontaneous
rate of polychromatic erythrocytes (PCEs) with
micronucleus, which consist about 3 micronuclei per 1000
PCEs (Rabello-Gay, 1991). Data indicated that the extract
does not present a mutagenic activity as reflect by the
mouse bone marrow micronucleus test.
DISCUSSION
The toxicological evaluation of a plant extract seeks
to determine its possible collateral effects, to ensure the
safety of use.
Some factors are capable to interfere in the toxicity
of medicinal plants extract. This toxicity can be intrinsic of
the vegetable drug or it happens during the process of
extract preparation (Bacchi, 1996). The toxicity of the drug
is related to its compound(s), and could be attributed to the
active principle or not.
With the aim to guarantee the quality and safety of
phytomedicines, the National Agency of Sanitary
Surveillance (ANVISA) published in 2000 the Resolution
- RDC n°17, (Brazil,  2000), establishing that
phytomedicines should present scientific studies that
check for the safety use of the medicine by pre-clinic and
clinical toxicology. It is, however, the Directive n°116/96
of the Secretary-ship of Sanitary Surveillance of the
Ministry of the Health (Brazil, 1996), that establishes the
 TABLE I - Hematological parameters of rats treated or not with 500 mg/kg body wieght of Pothomorphe umbellata
crude dried ethanolic extract by gavage during 40 days, 5 days per week
Group Leukocytes Erythrocytes Hemoglobin Packed cell volume
(cells/mm3) (cellsx106/mm3) (g/dl) (mg/dl)
Male
Control 2570 ± 708 8,275 x 106 ± 0,795 17,27 ± 0,764 45,67 ± 3,336
Treated  3350 ± 1444 8,226 x 106 ± 0,299 16,93 ± 0,968 45,60 ± 1,897
Female
Control 2020 ± 449 7,01 x 106 ± 1,16 14,75 ± 1,790 39,10 ± 5,173
Treated 2340 ± 688 7,69 x 106 ± 0,35 15,86 ± 0,748 42,00 ± 2,00
TABLE II - Biochemical parameters of serum of rats treated or not with 500 mg/kg body wieght of Pothomorphe
umbellata crude ethanolic dried extract by gavage during 40 days, 5 days per week
Group T P Glucose Cholesterol Tryglycerides Urea Creatinine ALT AST
(g/dl) (mg/dl) (mg/dl) (mg/dl) (mg/dl) (mg/dl) (UI/L) (UI/L)
Male
Control 6.64±0.15 116.8±15.96 80.7±12  50.1±8.50 59.1±4.93 0.75±0.08 49.7±6.77 37.6±7.87
Treated 6.25±0.40* 124.9±21.69 77.5±10.61 69.7±16.17* 57.6±8.29 0.71±0.05 56.2±9.60 42.5±13.76
Female
Control 6.27±0.50 136.5±40.86 70.8±16.86 76.7±27.91 49.5±7.63 0.69±0.08 62.1±13.00 34.7±8.9
Treated 5.74±0.85* 107.9±30.47 66.7±5.92 77.7±17.31 44.5±7.11 0.7±0.09 47±8.46* 37.3±12.23
ALT – alanine amino transferase, AST – aspartate amino transferase, T P – total proteins; * Significant, P ≤ 0.05
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rules for studies of the toxicity of these products.
A great number of phytomedicines frequently
employed in the therapeutic practice are obtained by
ethanolic percolation. In the present work, the dried
ethanolic root extract of Pothomorphe umbellata L. Miq
was used seeking to reproduce the pharmaceutical
preparation mentioned in Brazilian Pharmacopoeia (Silva,
1929) and assure total removing of the alcohol, substance
that could interfere in the evaluation of the toxicity
(Scivoletto & Malbergier, 1996).
In this work we evaluated the oral acute toxicity of
the dried ethanolic root extract of Pothomorphe
umbellata L. Miq. employing the Limit Dose test that allows
evaluating the lethality potential and the possible toxicant
effects developed in a short period of time (United States,
1992).
Acute toxicity study indicated that water suspension
of Pothomorphe umbellata L. Miq. crude ethanolic
extract is not toxic when administered by the oral route to
experimental animals. Similar results were described by
Bacchi et al. (1995), in a study with hydroalcoholic
extracts of Styrax camporum and Caesalpinia ferrea,
and Nyarko et al. (1999), with the aqueous extract of
Indigofera arrecta. Our results were comparable with
these ones, due to the likeness in the classification of the
phenolic compounds (in agreement with the basic skeleton
- C6 - radical) (Carvalho et al., 1999) present in the
extracts, to the form and to the administration period.
To the likeness of the acute study, the results of
weight variations and consumption of water and food after
repeated doses (subchronic treatment) did not present also
any significant alterations after subchronic treatment.
Regarding serum biochemical parameters, a
decrease of 6% and 8% was observed in total protein
concentration in males and females, respectively.
Tryglycerides were increased by 39% in males relatively
to the control group. AST activity were decreased by 24%
only in females. In spite of these significant variations, the
mean values were in the normal range described for the
animal species employed in the study (Lang, 1993).
Hematological parameters of treated rats were not
different from the controls and are also within the values
described in the literature for this animal specie (Andrew,
1965; Archer et al., 1977; Birgel Junior et al., 1986; Jain
et al., 1986; Jain, 1993).
Macro and microscopic examinations of the selected
organs did not reveal abnormalities that could be ascribed
to Pothomorphe umbellata L. Miq. administration.
The ethanolic dried root extract of Pothomorphe
umbellata L. Miq. employed in the experiments presented
approximately 6.5% of 4-nerolidilcatecol, a phenolic
compounds with high antioxidant activity (Barros et al.,
1996). Considering that phenolic compounds, like BHT and
BHA, can present mutagenic or carcinogenic properties
(Williams et al., 1999; Botterweck et al., 2000; Chung et
al., 2000), it was accomplished in this work the evaluation
of the mutagenicity by the micronucleus test. This test
approaches the real situation of therapeutics considering
that it is an in vivo test. In many cases, positive in vitro
mutagenicity tests are not obligatorily positive in vivo,
because substances with mutagenic activity present in the
extract can be not absorbed, minimizing, in this way, its
mutagenic potential.
It is the case of the Tinnevelly senna (Senna), plant
usually used as laxative, whose dry aqueous extract of
beans or leaves presents positive results in the in vitro
Ames test and in the Chinese hamster ovary cells (CHO)
assay. Mengs et al. (1999) evaluated the genotoxic
activity of the aqueous extract of this plant in a genotoxicity
in vivo assay using the bone marrow micronucleus test
and obtained negative results. The positive in vitro results
of extract of Tinnevelly senna are probably related to the
presence of the aloemodin and emodin anthraquinones that
produced mutagenic effects in several assays in vitro.
TABLE III - Relative and absolutive frequency of micronuclei in bone marrow cells of mice treated or not with
Pothomorphe umbellata crude ethanolic dried extract by gavage
GROUPa ABSENCE (%)/A PRESENCE (%)/A
Cyclophosphamide (PC) 50 mg/kg 96,98/14548  3.01*/452*
Distillated water (NC) 99,96/14995  0.03/5
Extract 1 g/kg 99,96/14994  04**/6**
Extract 2 g/kg 99,95/14992  0.05**/8**
Extract 5 g/kg 99,93/14992  0.07**/11**
* significant when compared with the distillated water treted group - P ≤ 0.05
**significant when compared with cyclophosphamide treated group - P ≤ 0.05
PC – positive control; NC – negative control
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However, these compounds did not present results in the
assays in vivo. Considering that the concentrations for
aloemodin and emodin in the plasma are distinctly lower
(<0.065 µg/mL) in relation to an elevated dose of the
extract of Tinnevelly senna (2000 mg/kg) and that the
values of these substances in the human plasma in
therapeutics conditions are inferior to 0.2 ng/mL, the
authors concluded there not to be a genotoxic risk for the
therapeutic use of the Senna as laxative, and that the in
vitro results were overestimated.
The literature is absent in relationship to the toxicity
evaluation of extracts of Pothomorphe umbellata L. Miq.,
as well as of its components. Only Mongelli et al. (1999)
reported the citotoxicity of 4-nerolidylcatechol
demonstrating that, by a mechanism of inhibition of the
activity of topoimerase I, this substance induces growth
inhibition of KB cells.
The results of the micronucleus test presented in this
work corroborate the study of Felzenszwalb et al. (1987)
that described the absence of mutagenicity of the dried
ethanolic root extract of Pothomorphe umbellata L. Miq.,
when the Ames test was employed.
Putting together, the results presented in this paper
conclude for the absence of oral toxicity of the dried
ethanolic root extract of Pothomorphe umbellata L. Miq.
after water suspension administration to laboratory
animals.
CONCLUSIONS
A single oral dose of 1, 2 and 5 g/kg w. b. of dried
ethanolic root extract of Pothomorphe umbellata L. Miq.
(“Limit test), was unable to induce mortality or toxic effects
in rats and mice. Similarly, subchronic toxicity test in rats,
dosed 500 mg/kg, 5 days per week during 40 days
demonstrated that the extract is innocuous. The bone
marrow micronucleus test showed no mutagenic activity
at the doses of 1, 2 and 5 g/kg. In summary, the data on the
acute and subchronic studies indicate the low toxicity and
the absence of mutagenic activity of Pothomorphe
umbellata L.Miq crude dried ethanolic extract.
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RESUMO
Avaliação da toxidade oral aguda e subcrônica de
extrato etanólico de Pothomorphe umbellata
L. Miq. (Parapiroba)
Existe uma grande preocupação quanto ao uso segu-
ro de extratos vegetais e, por esta razão, a necessida-
de de estudos toxicológicos pré-clínicos e clínicos des-
tes extratos. O objetivo deste trabalho foi o de avali-
ar a toxicidade aguda e subcrônica do extrato
hidroalcoólico liofilizado de Pothomorphe umbellata
L. Miq., administrado por via oral para animais de la-
boratório. O potencial mutagênico do extrato foi tam-
bém avaliado pelo teste do micronúcleo. Os resultados
dos estudos a curto e médio prazo demonstraram que
o extrato não apresenta propriedades tóxicas.
UNITERMOS: Pothomorphe umbellata L. Miq.. Avalia-
ção da toxicidade oral aguda. Avaliação da
toxicidade oral subcrônica. Avaliação mutagênica.
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